Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001839882-25-011945
Filing Date
2025-02-27
Accepted
2025-02-27 18:42:45
Documents
1
Period of Report
2025-02-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 - FOGARTY fogarty-form4_022725.html 4  
1 FORM 4 - FOGARTY fogarty-form4_022725.xml 4 6366
  Complete submission text file 0001839882-25-011945.txt   7947
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP. 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address
Fogarty Siobhan (Reporting) CIK: 0002055825 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36019 | Film No.: 25681620